Top Cities for Juvenile Arthritis Clinical Trials
Juvenile Arthritis clinical trials are recruiting across 10 cities. Here are the cities with the most active studies:
About Juvenile Arthritis
Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children, causing joint inflammation, pain, and stiffness. It encompasses several subtypes with varying patterns. Treatment includes NSAIDs, DMARDs, biologics, and physical therapy.
Clinical trials are advancing new treatments for juvenile arthritis. Currently, 1 studies are recruiting a combined 90 participants across the United States. Research is being conducted by 1 organizations including AbbVie.
2026 Juvenile Arthritis Research Landscape
As of March 2026, the juvenile arthritis clinical trial landscape includes 1 actively recruiting studies across 10 cities in the United States. These studies are collectively seeking 90 participants, with an average enrollment target of 90 per study.
Research is being led by 1 organization, including AbbVie.
Geographically, juvenile arthritis trials are most concentrated in Phoenix, Arizona (1 trial); Valhalla, New York (1 trial); Charlotte, North Carolina (1 trial); Cincinnati, Ohio (1 trial); Portland, Oregon (1 trial) and 5 other cities.
Featured Juvenile Arthritis Studies
Highlighted recruiting studies for juvenile arthritis, selected by enrollment size and research scope.
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Juvenile Idiopathic Arthritis (JIA) is the most common type of arthritis that affects children. The term "idiopathic" means "of unknown origin". It is a chronic (long-lasting) disease that causes swelling, warmth, and pain of one or more small joints. Systemic JIA ia a rare and serious form of JIA. Systemic" means it may affect not only the joints but other parts of the body, including the liver, ...
Frequently Asked Questions About Juvenile Arthritis Clinical Trials
Are there juvenile arthritis clinical trials near me?
Yes, there are 1 juvenile arthritis clinical trials currently recruiting across 10+ cities in the United States, including Phoenix, Arizona; Valhalla, New York; Charlotte, North Carolina. Browse the studies above to find one at a location convenient for you.
How do I join a juvenile arthritis clinical trial?
To join a juvenile arthritis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are juvenile arthritis clinical trials free?
Yes, participation in juvenile arthritis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of juvenile arthritis treatments are being studied?
Current juvenile arthritis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in juvenile arthritis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 2, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov